Spanien - engelsk - HMA (Heads of Medicines Agencies)

boehringer ingelheim espaÑa - pimobendan 10 mg - capsule, hard - dogs non food - pimobendane

Portugal - engelsk - HMA (Heads of Medicines Agencies)

boehringer ingelheim espaÑa - pimobendan 10 mg - capsule, hard - dogs non food - pimobendane

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

bomax pty ltd - evening primrose oil, quantity: 1 g - capsule, soft - excipient ingredients: d-alpha-tocopherol; soya oil; gelatin; glycerol; purified water - well - aids or assists in maintenance or improvement of general well-being. skin1 - for the symptomatic relief of eczema skin3 - for the symptomatic relief of dermatitis skin9 - may assist in the management of eczema skin11 - may assist in the management of dermatitis mens4 - relief of premenstrual breast pain mens5 - for the symptomatic relief of pre-menstrual syndrome) mens9 - may assist in the management of pre-menstrual syndrome arth1 - aids in the temporary relief of the pain of arthritis or temporary relief of arthritic pain rheum4 - may assist in the management of rheumatism rheum - temporary relief of rheumatism or temporary relief of rheumatic pain arth4 - may help increase joint mobility associated with arthritis rheum2 - symptomatic relief of rheumatism * evening primrose oil is a valuable source of the omega 6 fatty acid gamma-linolenic acid. * supports the healing and repair of the skin. * may assist in the relief of flaking, scaling and itching of the skin. * relief of pre-menstrual symptoms/syndrome. * assists in the maintenance of a healthy cardiovascular system

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aulong development pty ltd - bovine colostrum powder, quantity: 225 mg (equivalent: bovine immunoglobulin g, qty 45 mg) - tablet, chewable - excipient ingredients: calcium phosphate; magnesium stearate; colloidal anhydrous silica; glucose monohydrate; whole dry milk; flavour - colostrum is the valuable fluid produced by mother cows during first 48 hours after birth. it contains immune and growth factors (45mg igg) and is good for growing children and all people.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

upjohn australia pty ltd - phenytoin -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

upjohn australia pty ltd - phenytoin sodium -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

upjohn australia pty ltd - phenytoin sodium -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; rice starch; oxidised maize starch; magnesium stearate - congestive heart failure; lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation: because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia: lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

salt synergy - 58717 - inhalation-therapy sodium chloride air purifier - intended to be used to produce, obtain and feed dry salt aerosol (dsa) into a prepared room for treatment and health-improving procedures with method of halotherapy (dry salt aerosoltherapy). the device is intended to aid the conduction of health-improving procedures, respiratory tract cleansing and hygiene procedures to assist in the prevention of the respiratory diseases.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aurora bioscience pty ltd - 13762 - stimulator, - shotblocker is a flexible plastic disk that features a number of short, blunt skin contact points on its underside and an opening through which injections are administered. shotblocker stimulates the skin at the injection site. the sensation this produces closes the gate to block the flow of pain signals to the brain. the gate control theory of has proven valuable in understanding the body's regulation of pain, shotblocker is the 1st device to use this approach to reduce the pain of injections.